Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-06
DOI
10.1038/s41598-018-28484-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration
- (2018) Eveline Kersten et al. SURVEY OF OPHTHALMOLOGY
- Polypoidal Choroidal Vasculopathy
- (2016) Chandrakumar Balaratnasingam et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy
- (2015) Soo Hyun Kwon et al. OPHTHALMOLOGY
- PACHYCHOROID NEOVASCULOPATHY
- (2015) Claudine E. Pang et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Pachychoroid neovasculopathy and age-related macular degeneration
- (2015) Masahiro Miyake et al. Scientific Reports
- Stress, Inflammation, and Defense of Homeostasis
- (2014) Raj Chovatiya et al. MOLECULAR CELL
- Aqueous Humor Cytokine Levels in Patients with Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration
- (2014) Yoichi Sakurada et al. OPHTHALMIC RESEARCH
- PROFILE OF INTRAOCULAR IMMUNE MEDIATORS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION AND THE EFFECT OF INTRAVITREAL BEVACIZUMAB INJECTION
- (2014) Tsuyoshi Agawa et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PACHYCHOROID PIGMENT EPITHELIOPATHY
- (2013) David J. Warrow et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Relationship Between Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Choroidal Vascular Hyperpermeability
- (2012) Hideki Koizumi et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration
- (2012) M. Suzuki et al. JOURNAL OF CELL SCIENCE
- Mechanism of Inflammation in Age-Related Macular Degeneration
- (2012) Francesco Parmeggiani et al. MEDIATORS OF INFLAMMATION
- TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2012) Adrian T. Fung et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Subfoveal Retinal and Choroidal Thickness After Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- (2011) Ichiro Maruko et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aqueous Humor Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Bevacizumab in Type 3 Versus Type 1 and 2 Neovascularization. A Prospective, Case-Control Study
- (2011) Roberto Dell'Omo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Monocyte chemoattractant protein-1 in the aqueous humour of patients with age-related macular degeneration
- (2011) Michal Kramer et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Snake Venom Vascular Endothelial Growth Factors (VEGF-Fs) Exclusively Vary Their Structures and Functions among Species
- (2009) Yasuo Yamazaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neovascular Age-related Macular Degeneration: Intraocular Cytokines and Growth Factors and the Influence of Therapy with Ranibizumab
- (2009) Marion Funk et al. OPHTHALMOLOGY
- The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited
- (2009) Don H. Anderson et al. PROGRESS IN RETINAL AND EYE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started